Skip to main content

Advertisement

Log in

Pulmonary embolism after tadalafil ingestion

  • Case Report
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor that is used to treat male erectile dysfunction. It is currently undergoing clinical trials for the treatment of pulmonary hypertension. Although at present there is no evidence of hypercoagulation states being associated with the use of PDE5 inhibitors, several studies suggest that PDE5 inhibitors may, in rare cases, cause arterial and venous thrombotic or embolic events in the heart, eye, brain, and ear. We report a 54-year-old male patient with reduced plasma levels of protein C who developed pulmonary embolism (PE) just after he started taking tadalafil. The Naranjo probability scale indicates tadalafil as the possible cause of a PE in our patient. To the best of our knowledge, this is the first case report of tadalafil-induced PE in the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Benedict N, Seybert A, Mathier MA. Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin Ther. 2007;29:2134–53.

    Article  PubMed  CAS  Google Scholar 

  2. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996;8:47–52.

    PubMed  CAS  Google Scholar 

  3. Feenstra J, van Drie-Pierik RJ, Laclé CF, Stricker BH. Acute myocardial infarction associated with sildenafil. Lancet. 1998;352:957–8.

    Article  PubMed  CAS  Google Scholar 

  4. Tripathi A, O’Donnell NP. Branch retinal artery occlusion; another complication of sildenafil. Br J Ophthalmol. 2000;84:934–5.

    Article  PubMed  CAS  Google Scholar 

  5. Morgan JC, Alhatou M, Oberlies J, Johnston KC. Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology. 2001;57:1730–1.

    PubMed  CAS  Google Scholar 

  6. Cunningham AV, Smith KH. Anterior ischemic optic neuropathy associated with viagra. J Neuroophthalmol. 2001;21:22–5.

    PubMed  CAS  Google Scholar 

  7. Mukherjee B, Shivakumar T. A case of sensorineural deafness following ingestion of sildenafil. J Laryngol Otol. 2007;121:395–7.

    Article  PubMed  CAS  Google Scholar 

  8. Rufa A, Cerase A, Monti L, Dotti MT, Giorgio A, Sicurelli F, et al. Recurrent venous thrombosis including cerebral venous sinus thrombosis in a patient taking sildenafil for erectile dysfunction. J Neurol Sci. 2007;260:293–5.

    Article  PubMed  CAS  Google Scholar 

  9. Turko IV, Ballard SA, Francis SH, Corbin JD. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Mol Pharmacol. 1999;56:124–30.

    PubMed  CAS  Google Scholar 

  10. Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M. Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep. 2007;59:150–63.

    PubMed  CAS  Google Scholar 

  11. Corbin JD, Beasley A, Blount MA, Francis SH. High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors. Biochem Biophys Res Commun. 2005;334:930–8.

    Article  PubMed  CAS  Google Scholar 

  12. Kabrhel C, McAfee AT, Goldhaber SZ. The probability of pulmonary embolism is a function of the diagnoses considered most likely before testing. Acad Emerg Med. 2006;13:471–4.

    Article  PubMed  Google Scholar 

  13. Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol. 1999;83:35C–44C.

    Article  PubMed  CAS  Google Scholar 

  14. Gorkin L, Hvidsten K, Sobel RE, Siegel R. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract. 2006;60:500–3.

    Article  PubMed  CAS  Google Scholar 

  15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

None

Funding

None

Conflicts of Interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huang-Chi Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, HC., Wang, CS., Chuang, SH. et al. Pulmonary embolism after tadalafil ingestion. Pharm World Sci 30, 610–612 (2008). https://doi.org/10.1007/s11096-008-9229-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-008-9229-0

Keywords

Navigation